Evidence map›Paper›PMID 34053396›Full record

ArticleVirulence2021

Reduction of endotoxicity in Bordetella bronchiseptica by lipid A engineering: Characterization of lpxL1 and pagP mutants.

Jesús Pérez-Ortega, Roel M Van Harten, Ria Van Boxtel, Michel Plisnier, Marc Louckx, Dominique Ingels, Henk P Haagsman, Jan Tommassen

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Engineering low-endotoxin lipid A in a double auxotrophFrontiers in cellular and infection microbiology · 2026
    Article
  3. LpxR and PagL expression in live attenuated auxotrophicFrontiers in cellular and infection microbiology · 2025
    Article
  4. Dual role ofiMetaOmics · 2024
    Article
  5. Review
  6. Biosynthesis of the Inner Core ofInternational journal of molecular sciences · 2023
    Article
  7. Regulated Expression ofInternational journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jesús Pérez-OrtegaSection Molecular Microbiology, Department of Biology, Faculty of Science, Utrecht University, Utrecht, Netherlands.ORCID 0000-0002-8022-499X
Roel M Van HartenSection of Molecular Host Defense, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
Ria Van BoxtelSection Molecular Microbiology, Department of Biology, Faculty of Science, Utrecht University, Utrecht, Netherlands.
Michel PlisnierGSK, Rixensart, Belgium.
Marc LouckxGSK, Rixensart, Belgium.
Dominique IngelsGSK, Rixensart, Belgium.
Henk P HaagsmanSection of Molecular Host Defense, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
Jan TommassenSection Molecular Microbiology, Department of Biology, Faculty of Science, Utrecht University, Utrecht, Netherlands.
Utrecht University · NLGlaxoSmithKline (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-cell vaccines against Gram-negative bacteria commonly display high reactogenicity caused by the endotoxic activity of lipopolysaccharide (LPS), one of the major components of the bacterial outer membrane. Underacylation of the lipid A moiety of LPS has been related with reduced endotoxicity in several Gram-negative species. Here, we evaluated whether the inactivation of two genes encoding lipid A acylases of

Indexed as

Bordetella bronchisepticaLipid AAnimalsAntimicrobial PeptidesLipopolysaccharidesMiceSwineToll-Like Receptor 4Antimicrobial PeptidesLipid ALipopolysaccharidesToll-Like Receptor 4antimicrobial susceptibilityautoaggregationbiofilmsBordetellaendotoxicityLPSLpxL1PagPTLR4vaccine

Identifiers

PMID34053396
PMCPMC8168481
OpenAlexW3165854959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.